| Authors: |
Ward MC; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Southeast Radiation Oncology Group, Charlotte, North Carolina. Electronic address: matthew.ward@atriumhealth.org., Koyfman SA; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Bakst RL; Mount Sinai Icahn School of Medicine, New York, New York., Margalit DN; Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts., Beadle BM; Stanford University School of Medicine, Palo Alto, California., Beitler JJ; Knox County Health Clinic, Rockland, Maine., Chang SS; Henry Ford Cancer Institute, Detroit, Michigan., Cooper JS; Retired., Galloway TJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Ridge JA; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Robbins JR; University of Arizona College of Medicine Tucson, Tucson, Arizona., Sacco AG; University of California San Diego Moores Cancer Center, La Jolla, California., Tsai CJ; Memorial Sloan Kettering Cancer Center, New York, New York., Yom SS; University of California, San Francisco, California., Siddiqui F; Henry Ford Cancer Institute, Detroit, Michigan. |